Since AMY/CTR complexes are localized on microglia, depletion of these target receptors for Aβ could attenuate the amyloid-induced neuroinflammation, including the cytokine release that is known to upregulate APP processing and thereby increase the rate of Aβ generation [23]. The gene discussed is APP; the disease is amyloidosis.